Avanos Medical, Inc.
AVNSDelisted Jul 27, 2026- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001606498
Avanos Medical, Inc. was delisted on Jul 27, 2026; its insiders filed their last Form 4 on Jul 28, 2026; 286 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor held it.
Holders of 5% or more of AVNS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Avanos Medical, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 14.80%6.83M shares | – | Apr 30, 20251 filing | Apr 30, 2025 | SEC |
| T. Rowe Price Investment Management, Inc. | 13G/A | 10.20%4.71M shares | +2.00 ppfrom 8.20% | Feb 14, 20253 filings | Oct 7, 2025 | SEC |
| Vanguard Group Inc | 13G/A | 7.38%3.43M shares | −2.27 ppfrom 9.65% | Jul 29, 20252 filings | Oct 30, 2025 | SEC |
| RGM Capital, LLC | 13G/A | 6.50%2.99M shares | – | Feb 13, 20251 filing | Feb 13, 2025 | SEC |
| Armistice Capital, LLC | 13G | 5.39%2.50M shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Dimensional Fund Advisors LP | 13G/A | 5.10%2.35M shares | – | Oct 9, 20251 filing | Oct 9, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Avanos Medical, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20256:39 PM ET | Armistice Capital, LLCand 1 other | 13G | 5.39%2.50M shares | New | Sep 30, 2025 | SEC |
| Oct 30, 20252:26 PM ET | Vanguard Group Inc | 13G/A | 7.38%3.43M shares | −2.27 ppfrom 9.65% | Sep 30, 2025 | SEC |
| Oct 9, 20251:48 PM ET | Dimensional Fund Advisors LP | 13G/A | 5.10%2.35M shares | – | Sep 30, 2025 | SEC |
| Oct 7, 202512:51 PM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 10.20%4.71M shares | +2.00 ppfrom 8.20% | Sep 30, 2025 | SEC |
| Jul 29, 202511:24 AM ET | Vanguard Group Inc | 13G/A | 9.65%4.46M shares | – | Jun 30, 2025 | SEC |
| May 14, 202510:47 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 8.20%3.76M shares | +1.60 ppfrom 6.60% | Mar 31, 2025 | SEC |
| Apr 30, 202512:02 PM ET | BlackRock, Inc. | 13G/A | 14.80%6.83M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20259:45 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 6.60%3.01M shares | – | Dec 31, 2024 | SEC |
| Feb 13, 20255:53 PM ET | RGM Capital, LLC | 13G/A | 6.50%2.99M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Avanos Medical, Inc. shares.
No Form 144 notices for Avanos Medical, Inc. are on file.